Identification of binding proteins for PSP94 in human prostate adenocarcinoma cell lines LNCaP and PC-3

Prostate

Volumn 35, Issue 1, 1998, Pages 11-17

  Yang, Jing Ping ^a,b   Baijal Gupta, Madhulika ^b   Garde, Seema V ^b   Fraser, Jennifer E ^b   Finkelman, Malcolm A ^b   Clarke, Michael W ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b Procyon Biopharma Inc   (Canada)

Author keywords

Binding sites; LNCaP; PC 3; Prostate; PSP94

Indexed keywords

BINDING PROTEIN; BIOTIN; PROSTATE PROTEIN; SECRETORY PROTEIN;

ARTICLE; BINDING AFFINITY; BINDING SITE; CARCINOMA CELL; CELL LINE; COMPETITIVE INHIBITION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROSTATE; PROSTATE ADENOCARCINOMA; SCATCHARD PLOT;

ADENOCARCINOMA; BINDING, COMPETITIVE; BIOTINYLATION; CARRIER PROTEINS; CELL COUNT; CHROMATOGRAPHY, AFFINITY; HUMANS; KINETICS; MALE; PROSTATIC NEOPLASMS; PROSTATIC SECRETORY PROTEINS; PROTEINS; SEMINAL PLASMA PROTEINS; TEMPERATURE; TUMOR CELLS, CULTURED;

EID: 0031944102     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19980401)35:1<11::AID-PROS2>3.0.CO;2-K     Document Type: Article

References (26)

1. Seidah NG, Abrabatti NJ, Rochemeny J, Sheth AR, Cheretien M: Complete amino acid sequence of human seminal plasma ß-inhibin. Prediction of post Gln-Arg cleavage as a maturation site. FEBS Lett 1984;175:349-355.
2. Johasson J, Sheth A, Cederlund E, Jornall H: Analysis of an inhibin preparation reveals apparent identity between a peptide with inhibin-like activity and a sperm-coating antigen. FEBS Lett 1984;1976:21-26.
3. Akiyama K, Yoshida Y, Schmid K, Offner GD, Troxler RF, Tsuda R, Hara M: The amino acid sequence of human ß-microseminoprotein. Biochim Biophys Acta 1985;829:288-294.
4. Ulvsback M, Lindstrom C, Weiber H, Abrahamsson PA, Lilija H, Lundwall A: Molecular cloning of a small prostate protein, known as ß-microseminoprotein, PSP94 or ß-inhibin, and demonstration of transcriptions in non-genital tisstues. Biochem Biophys Res Commun 1989;164:1310-1315.
5. Green CB, Lui WY, Kwok SCM: Cloning and nucleotide sequence analysis of the human ß-microseminoprotein. Biochem Biophys Res Commun 1990;167:1184-1190.
6. Doctor VM, Sheth AR, Simha MM, Arbatti JP, Sheth N: Studies on immunocytochemical location of inhibin-like material in human prostatic tissue: Comparison of its distribution in normal, benign and malignant prostate. Br J Cancer 1990;53:547-554.
7. Sathe VS, Sheth NA, Phadke MA, Sheth AR, Zaverl JP: Biosynthesis and localization of inhibin in human prostate. Prostate 1987;10:33-43.
8. Weiber H, Anderson C, Murne A, Ranevik G, Lindstrom C, Lilja H, Fernlund P: ß-microseminoprotein is not a prostate-specific protein: Its identification in mucous and secretions. Am J Pathol 1990;137:593-603.
9. Kharbanda K, Dhingra SR, Duraiswami S: Secretion of inhibinlike material by rat ventral prostate epithelial cells in culture. Prostate 1991;18:59-71.
10. Ohkubo I, Tada T, Ochiai Y, Ueyama H, Eimoto T, Sasaki M: Human seminal plasma ß-microseminoprotein: Its purification, characterization and immunohistochemical localization. Int J Biochem Cell Biol 1995;27:603-611.
11. Hyakutake H, Sakai H, Yogi Y, Tsuda R, Minami Y, Yushita Y, Kanetake H, Nakazono I, Saito Y: Beta-microseminoprotein immunoreactivity as a new prognostic indicator of prostatic carcinoma. Prostate 1993;2:347-355.
12. Brar A, Mbikay M, Sirois F, Fournier S, Seidah NG, Chretien M: Localization of the human prostatic secretory protein PSP94 and its mRNA in the epithelial cells of the prostate. J Androl 1998; 9:253-260.
13. Liu AY, Bradner RC, Vessella RL: Decreased expression of prostatic secretory protein PSP94 in prostate cancer. Cancer Lett 1993;74:91-99.
14. Garde S, Sheth AR, Porter AT, Pienta KJ: Effect of prostatic inhibin peptide (PIP) on prostate cancer cell growth in vitro and in vivo. Prostate 1993;22:225-233.
15. Lokeshwar BL, Hurkadli KS, Sheth AR, Block NL: Human prostatic inhibin suppresses tumour growth and inhibits clonogenic cell survival of a model prostatic adenocarcinoma, the Dunning R3327G rat tumour. Cancer Res 1993;53:4855-4859.
16. Phadke M, Vijayalakshmi S, Sheth AR: Evidence for the presence of specific receptors for inhibin in human prostate. Ind J Exp Biol 1982;20:419-420.
17. Baijal-Gupta M, Fraser JE, Clarke MW, Xuan JW, Finkelman MA: A new scalable purification procedure for prostatic secretory protein (PSP94) from human seminal plasma. Protein Expr Purif 1996;8:483-488.
18. Saggio I, Paonessa G, Gloaguen I, Graziani R, Serio AD, Laufer R: Nonradioactive receptor binding assay for ciliary neurotropic factor. Anal Biochem 1994;221:387-391.
19. Green NM: A spectrophotometric assay for avidin and biotin based on a binding of dyes by avidin. Biochem J 1965;94:23C-24C.
20. Yang JP, Cherian MG: Preventive effect of metallothionein on streptozotocin-induced diabetes in rats. Life Sci 1994;55:43-46.
21. Brun GL, Moldovan F, Aubin P, Ropiquet F, Cussenot O, Fiet J: Identification of endothelin receptors in normal and hyperplasic human prostate tissues. Prostate 1996;28:379-384.
22. Schenle EJ, Adams LD, Sammons DW: Insulin-induced rapid decrease of a major protein in fat cell plasma membranes. J Biol Chem 1984;259:12112-12116.
23. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the folin phenol reagent. J Biol Chem 1951;193: 265-275.
24. Cunha GR: Growth factors as mediators of androgen action during male urogenital development. Prostate Suppl 1996;6:22-26.
25. Scher HI, Sarkis A, Reuter V, Cohen D, Netto G, Petrylak D, Lianes P, Fuks Z, Mendesohn J, Cordon-Cardo C: Changing pattern of expression of the epidermal growth factor receptor and transforming growth factor in the progression of prostatic neoplasms. Clin Cancer Res 1995;1:545-550.
26. Culig Z, Hobisch A, Cronauer MV, Radmayr C, Hittmair A, Zhang J, Thurnher M, Bartsch G, Klocker H: Regulation of prostatic growth and function by growth factors. Prostate 1996;28: 392-405.